Format

Send to

Choose Destination
See comment in PubMed Commons below
Int Arch Allergy Immunol. 2013;160(4):346-9. doi: 10.1159/000343883. Epub 2012 Nov 21.

100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco.

Author information

1
Allergy and Respiratory Disease Clinic, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy. canonica@unige.it

Abstract

Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.

PMID:
23183050
DOI:
10.1159/000343883
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Support Center